To look more closely at the expression and roles of 7,9-O- and 9-O-Ac modifications and their effects on viral infections, we prepared glycoengineered cell lines that lacked these modifications or that expressed higher levels of CasD1. The gene discussed is CASD1; the disease is viral infectious disease.